Related Experiment Video
Updated: Jan 18, 2026
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Utilization of Chimeric Antigen Receptor T-cell Therapy in Adults
Channing Vail Dudley1, Brittney Baer1, Rhea Micci Simons1
1Hematology-Oncology Program, Vanderbilt-Ingram Cancer Center, Nashville, TN.
Objective:
To discuss the mechanism of action and nursing care of adults receiving chimeric antigen receptor (CAR) T-cell therapy.
Data Source:
Peer reviewed articles and pharmaceutical drug labels.
Conclusion:
CAR T-cell therapy is among the most exciting therapies in the evolution of cancer treatment. The efficacy of research with CAR T-cell therapy has shown promising results in hematologic malignancies as well as in solid tumors.
Implications For Nursing Practice:
Understanding the complexity of care for these patients from the bedside to the outpatient setting is vital for their survival and quality of care.
